NATIONAL NEWS

Trump’s drugmaker deals may save economy $529B over 10 years, White House says

May 5, 2026, 7:02 AM

President Donald Trump arrives to speak at a charter school in The Villages, Fla., Friday, May 1, 2...

President Donald Trump arrives to speak at a charter school in The Villages, Fla., Friday, May 1, 2026. (AP Photo/Matt Rourke)
Credit: ASSOCIATED PRESS

(AP Photo/Matt Rourke)

WASHINGTON (AP) — White House economists estimate that President Donald Trump’s deals with pharmaceutical companies to drop some of their U.S. prescription drug prices to what they charge in other countries could save $529 billion over the next 10 years.

The analysis obtained by The Associated Press includes the first economy-wide projections behind a policy at the core of Trump’s pitch to voters going into November’s midterm elections for control of the House and Senate. Democratic lawmakers have been doubtful about the savings claimed by Trump and these new numbers are likely to trigger additional questions about the data.

Cost-of-living issues are at the forefront of voters’ concerns and higher energy prices tied to the Iran war have deepened the public’s anxiety. Trump has tried in part to address affordability concerns by focusing on his efforts to cut deals with companies so that the cost of prescription drugs in the U.S. would no longer be dramatically higher than in other affluent nations.

“Now you have the lowest drug prices anywhere in the world,” Trump said at a Friday rally before a crowd of seniors in Florida. “And that alone should win us the midterms.”

The analysis was done by administration officials for the White House Council of Economic Advisers. They also estimated that federal and state governments could save a combined $64.3 billion on Medicaid during the next decade because of what Trump calls his “most favored nation” policy on drug prices.

Few of the details of the deals struck by the Trump administration and 17 leading pharmaceutical companies have been made public, making it hard to independently verify the projected savings. The White House analysis sought to estimate the prospective savings as more medications come onto the market and fall under Trump’s framework — with one model in the report tallying the possible savings at $733 billion over a decade.

Trump and his Department of Health and Human Services have touted his drug-pricing deals as transformative and urged Congress to codify their principles into law. Democratic lawmakers have challenged the administration’s claims of savings. Senate Finance Committee Ranking Member Ron Wyden, D-Ore., and 17 Senate Democrats in April proposed a measure requiring the administration to disclose the terms of the agreements signed by pharmaceutical companies.

“If these deals are so great, why is the Trump administration afraid of showing them to the public?” Wyden said when announcing the measure. Health Secretary Robert F. Kennedy Jr. said his team would share details that didn’t include proprietary information or trade secrets.

The potential savings estimated by the Trump administration would be substantial as Americans spent $467 billion on prescription drugs in 2024, according to the most recent government data available. The analysis is premised on the idea that foreign countries would also pay more for their prescription drugs, which would diversify drugmakers’ sources of revenue and preserve their ability to innovate with new treatments.

The Congressional Budget Office in October 2024 estimated that a plan similar to what Trump ended up adopting could reduce prescription drug prices by more than 5%, though the decrease “would probably diminish over time as manufacturers adjusted to the new policy by altering prices or distribution of drugs in other countries.”

The scope of the savings claimed by the Trump administration are likely to intensify the scrutiny by Democrats, who counter that any price reductions would be offset by higher costs for prescription drugs not covered by the “most favored nation” framework. One of their main critiques is that pharmaceutical companies have increased their profit margins while working with the administration.

In April, staff working for Sen. Bernie Sanders, I-Vt., released an analysis that looked at 15 of the companies that have agreed to this drug-pricing plan and found that their combined profits jumped 66% over the past year to $177 billion. The report noted that the tax cuts Trump signed into law last year “exempted or delayed many of the most expensive drugs” from price negotiations with Medicare.

The Trump administration has countered that they consider Sanders’ critique to be flawed, saying that it’s based on the list prices for pharmaceutical drugs instead the actual price that patients pay.

National News

With the Washington Monument seen in the distance, a person golfs at the East Potomac Golf Links go...

Associated Press

Trump administration signals plan for seawall work at Washington golf course as legal fight drags on

WASHINGTON (AP) — The Interior Department has issued a notice that it intends to seek bids for a contractor to begin work on the seawall at a Washington park where President Donald Trump plans to redevelop a historic public golf course into a world-class venue. Those plans were put on hold by a judge over […]

48 minutes ago

FILE - Federal Reserve Board of Governors member Lisa Cook leaves the Supreme Court in Washington, ...

Associated Press

Federal Reserve’s Cook refuses to participate in White House hearing

WASHINGTON (AP) — Federal Reserve governor Lisa Cook declined through her lawyers to appear next month before a Trump administration committee that is considering whether she should be fired, calling the process unfair and committed to a predetermined outcome. The refusal extends the wrangling between the White House and Cook’s lawyers regarding her appearance before […]

59 minutes ago

FILE -Russian President Vladimir Putin, 2nd right, speaks with workers as he inspects the road sect...

Associated Press

The Kerch Bridge is crucial to Russia’s war effort and for asserting Moscow’s control of Crimea

There is perhaps no more potent symbol of Moscow’s illegal annexation of Crimea than the bridge connecting the peninsula with Russia over the Kerch Strait — and it has come under repeated Ukrainian attacks since the nearly 5-year-old war began. The Kerch Bridge is a key artery for military and civilian supplies to Crimea, which […]

2 hours ago

Attendees gather for a talking circle at the late Gloria Steinem’s brownstone, Tuesday, Nov. 10, ...

Associated Press

Gloria Steinem’s famed talking circles are still going strong. This one had a twist: Men only

NEW YORK (AP) — For more than half a century, Gloria Steinem welcomed guests into her inviting, art-filled Manhattan living room, gathering women from all walks of life to discuss issues of vital importance in health, education, business, politics and beyond. It was her long-held dream that these “talking circles” continue after she was gone […]

3 hours ago

FILE - U.S. Catholic bishops are seated at the Basilica of the National Shrine of Mary, Queen of th...

Associated Press

US Catholic bishops meet after Democrats’ big wins help reshape immigration and abortion debates

U.S. Catholic bishops are holding their annual fall meeting in Baltimore this week. The gathering comes just after Democrats’ sweeping midterm victories reset the political dynamics around some of the bishops’ priorities, including immigration, abortion and artificial intelligence. The U.S. Conference of Catholic Bishops is now facing a divided government as it seeks to influence […]

4 hours ago

A person walks up the stairs outside Nvidia HQ in Santa Clara, Calif., on Thursday, Nov. 12, 2026. ...

Associated Press

Nvidia establishes committee to oversee national security after abrupt departure of CEO Jensen Huang

Nvidia is creating a new board committee to oversee national security and global trade compliance following revelations that former CEO Jensen Huang had an extramarital affair with an alleged spy for China. Nvidia’s National Security and Export Control Oversight Committee will be responsible for oversight of national security policies and compliance with export controls, the […]

4 hours ago

Trump’s drugmaker deals may save economy $529B over 10 years, White House says